Figure 2.

The comparisons analyzed within the network, risk of bias of including studies and consistency test. (A) Network plot; (B) risk of bias graph; (C) risk of bias summary; (D) publication bias; (E) evaluation of inconsistency. A: CCRT; B: PF + CCRT; C: TP + CCRT; D: TPF + CCRT. PF, induction chemotherapy regimen of cisplatin, 5-fluorouracil; TP, induction chemotherapy regimen of docetaxel, cisplatin; TPF, induction chemotherapy regimen of docetaxel, cisplatin, 5-fluorouracil; CCRT, concurrent chemoradiotherapy.